Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation

A photodynamic technique for human breast cancer detection founded upon the ability of tumour cells to rapidly accumulate the fluorescent product protoporphyrin IX (PpIX) has been applied to transgenic mouse models of mammary tumorigenesis. A major goal of this investigation was to determine whether mouse mammary tumours are reliable models of human disease in terms of PpIX accumulation, for future mechanistic and therapeutic studies. The haeme substrate 5-aminolevulinic acid (5-ALA) (200 mg kg−1) was administered to mouse strains that develop mammary tumours of various histological subtypes upon expression of the transgenic oncogenes HRAS, Polyoma Virus middle T antigen, or Simian Virus 40 large T antigen in the mammary gland. Early neoplastic lesions, primary tumours and metastases showed consistent and rapid PpIX accumulation compared to the normal surrounding tissues, as evidenced by red fluorescence (635 nm) when the tumours were directly illuminated with blue light (380–440 nm). Detection of mouse mammary tumours at the stage of ductal carcinoma in situ by red fluorescence emissions suggests that enhanced PpIX synthesis is a good marker for early tumorigenic processes in the mammary gland. We propose the mouse models provide an ideal experimental system for further investigation of the early diagnostic and therapeutic potential of 5-ALA-stimulated PpIX accumulation in human breast cancer patients

Theoretical analysis of nucleation and growth of ZnO nanostructures in vapour phase transport growth

This paper discusses the growth atmosphere, condensing species and nucleation conditions relevant to vapour phase transport growth of ZnO nanostructures, including the molecular parameters and thermodynamics of the gas phase ZnO molecule and its importance compared to atomic Zn and molecular O2. The partial pressure of molecular ZnO in a Zn/O2 mix at normal ZnO growth temperatures is 6x10^-7 of the Zn partial pressures. In typical vapour phase transport growth conditions, using carbothermal reduction, the Zn vapour is always undersaturated while the ZnO vapour is always supersaturated. In the case of the ZnO vapour, our analysis suggests that the barrier to homogeneous nucleation (or heterogeneous nucleation at unseeded/uncatalysed areas of the substrates) is too large for nucleation of this species to take place, which is consistent with experimental evidence that nanostructures will not grow on unseeded areas of substrates. In the presence of suitable accommodation sites, due to ZnO seeds, growth can occur via Zn vapour condensation (followed by oxidation) and via direct condensation of molecular ZnO (whose flux at the surface, although less than that of Zn vapour, is still sufficient to yield an appreciable nanostructure deposit). The balance between these two condensing species is likely to be a sensitive function of growth parameters and could explain both the diversity of reported nanostructure morphologies and the challenges to be faced in developing reproducible and scalable growth systems for specific applicable morphologies

Maximum dynamic stress on bridges traversed by moving loads

Most current research on dynamic effects due to traffic load on simply supported bridges focuses on the mid-span section of the bridge, since this location corresponds to the worst static bending moment. However, the maximum total moment allowing for dynamics, may differ considerably from the maximum moment at mid-span. This paper shows how the maximum can occur in a section relatively far from mid-span with a significant difference in magnitude.Other funderJournal websitewww.bridgesjournal.comEuropean 6th Framework Programme ARCHES (Assessment and Rehabilitation of Central European Highway Structures)Publisher requires the journal URL to appear on the record: www.bridgesjournal.com. Could use Description web link: Journal website as in http://hdl.handle.net/10197/2437? - AV 1/11/2010 au ke SB. 15/11/'1

High incidence, early onset of histiocytic sarcomas in mice with Hertwig\u27s anemia.

OBJECTIVE: Histiocytic sarcoma (HS) is a rare, rapidly disseminated, usually lethal tumor in humans. Treatment specific for HS has not been developed primarily due to deficiencies of appropriate animal models with high incidence/early onset. Mice with Hertwig\u27s anemia (an/an) provide a potential model. METHODS: Here, we compare HS susceptibility in an/an and unaffected control mice maintained on three genetic backgrounds. As a potential therapeutic measure, genetically marked bone marrow is transplanted between high and low susceptibility animals. RESULTS: HS is detected earlier and the overall incidence is 15-fold higher in WBB6F1(F1)-an/an than in F1-+/?, B6-an/an and -+/? mice. Neither WB-an/an nor their normal WB-+/? littermates present with HS. Liver myelopoiesis and aneuploidy coexist with HS but the former is also rampant (33.7% incidence) in HS-free +/? and an/an mice. Marrow transplantation experiments provide evidence that (1) myelopoiesis is associated with HS and (2) early-onset/high-incidence HS is blocked by using late-onset F1-+/+ mice, as either donor or recipient. CONCLUSIONS: Homozygosity for an on an F1 genetic background is essential for high-incidence/early-onset HS; myelopoiesis and HS coexist; and therapeutic transplantation may be feasible